banner

AWS BIO-PHARMA TECHNOLOGIES, LLC

  • email
  • twitter
  • linkedin
  • facebook
By HemCon Medical Technologies, Inc. - Jan 23 2018
share
  • email
  • twitter
  • linkedin
  • facebook
Chitosan-Based Dressing for the Treatment of External/Accessible Bleedings in Children With Bleeding Tendency
Misgav M, et al. Journal of Pediatric Hematology/Oncology 2013: 00:000-000 This study reports findings on 6 bleeding episodes on 5 patients...
By HemCon Medical Technologies, Inc. - Apr 18 2016
share
  • email
  • twitter
  • linkedin
  • facebook
Tricol Completes Asset Acquisition of HemCon
Tricol International Group Limited Completes Asset Acquisition of HemCon Medical Technologies Inc. Global microfiber expert to stabilize and...
By HemCon Medical Technologies, Inc. - May 06 2015
share
  • email
  • twitter
  • linkedin
  • facebook
Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) a health and wellness company that targets opportunities in the advanced wound care...
By HemCon Medical Technologies, Inc. - Apr 18 2016
share
  • email
  • twitter
  • linkedin
  • facebook
Tricol International Group Limited Completes Asset Acquisition of HemCon Medical Technologies Inc
Global microfiber expert to stabilize and focus growth of Oregon based advanced wound care company
Tricol International Group Ltd., a...
By HemCon Medical Technologies, Inc. - Jan 05 2018
share
  • email
  • twitter
  • linkedin
  • facebook
Chitosan Pads Significantly Reduce Time to Hemostasis in Dialysis Patients With Coagulopathy
The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency. Misgav M., Lubetszki A., Brutman-Barazani...
By HemCon Medical Technologies, Inc. - Jan 05 2018
share
  • email
  • twitter
  • linkedin
  • facebook
Efficacy of Two Novel Hemostatic Agents in a Coagulopathic Model of Sever Hemorrhage and Other Agents.
Efficacy of Two Novel Hemostatic Agents in a Coagulopathic Model of Sever Hemorrhage and other agents. LCDE Ryan Buckley, et al. Combat Trauma...
https://media.caboodleai.net/pda/companies/83133f79-1a78-4af6-b4c7-561ba702a3d1.com.png
geo-icon
10578 State Hwy 337
Tijeras, NM, 87059
United States
Website: http://www.awsbiopharma.com